We expected to provide novel information regarding the role of the AGK and Hippo‐YAP1 pathways in the development of gastric cancer and determine whether they should be further evaluated as biomarkers for the early detection and prediction of prognosis in gastric cancer and explored as therapeutic targets for the treatment of gastric cancer. Here, YAP1 is linked to gastric cancer.